Related Experiment Video
Updated: Mar 7, 2026
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
Epinephrine for First-aid Management of Anaphylaxis
Scott H Sicherer1, F Estelle R Simons2,
1Professor of Pediatrics, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, New York; and.
Insights
Prompt epinephrine administration is crucial for managing anaphylaxis, a severe allergic reaction. This updated guidance emphasizes early diagnosis, appropriate epinephrine autoinjector (EA) use, and comprehensive community education for improved patient outcomes.
Area of Science:
- Pediatrics
- Allergy and Immunology
- Emergency Medicine
Background:
- Anaphylaxis is a life-threatening allergic reaction requiring immediate treatment.
- Epinephrine (adrenaline) is the first-line treatment for anaphylaxis.
- Previous guidelines from 2007 require updating to reflect current knowledge and practices.
Purpose of the Study:
- To provide an updated clinical report on anaphylaxis management for pediatricians.
- To offer guidance on identifying at-risk patients and using epinephrine autoinjectors (EAs).
- To highlight the importance of community-based education for anaphylaxis recognition and response.
Main Methods:
- Review of current literature and clinical evidence on anaphylaxis.
- Development of updated clinical criteria for diagnosis.
- Formulation of recommendations for epinephrine use and patient education.
Main Results:
- Validated clinical criteria aid prompt anaphylaxis diagnosis.
- Intramuscular epinephrine injection significantly reduces adverse outcomes.
- EAs facilitate timely treatment in community settings.
- Challenges exist in dosing epinephrine for infants and young children.
- Comprehensive community and family education is vital for effective management.
- Prevention strategies include trigger identification, avoidance, immunotherapy, and action plans.
Conclusions:
- Prompt diagnosis and intramuscular epinephrine are critical for anaphylaxis management.
- Epinephrine autoinjectors are essential tools, though dosing for infants requires consideration.
- A multi-faceted approach involving patients, families, and community organizations improves anaphylaxis care.
- Ongoing education and personalized emergency action plans are key to preventing recurrences and ensuring safety.
Abstract:
Anaphylaxis is a severe, generalized allergic or hypersensitivity reaction that is rapid in onset and may cause death. Epinephrine (adrenaline) can be life-saving when administered as rapidly as possible once anaphylaxis is recognized. This clinical report from the American Academy of Pediatrics is an update of the 2007 clinical report on this topic. It provides information to help clinicians identify patients at risk of anaphylaxis and new information about epinephrine and epinephrine autoinjectors (EAs). The report also highlights the importance of patient and family education about the recognition and management of anaphylaxis in the community. Key points emphasized include the following: (1) validated clinical criteria are available to facilitate prompt diagnosis of anaphylaxis; (2) prompt intramuscular epinephrine injection in the mid-outer thigh reduces hospitalizations, morbidity, and mortality; (3) prescribing EAs facilitates timely epinephrine injection in community settings for patients with a history of anaphylaxis and, if specific circumstances warrant, for some high-risk patients who have not previously experienced anaphylaxis; (4) prescribing epinephrine for infants and young children weighing <15 kg, especially those who weigh 7.5 kg and under, currently presents a dilemma, because the lowest dose available in EAs, 0.15 mg, is a high dose for many infants and some young children; (5) effective management of anaphylaxis in the community requires a comprehensive approach involving children, families, preschools, schools, camps, and sports organizations; and (6) prevention of anaphylaxis recurrences involves confirmation of the trigger, discussion of specific allergen avoidance, allergen immunotherapy (eg, with stinging insect venom, if relevant), and a written, personalized anaphylaxis emergency action plan; and (7) the management of anaphylaxis also involves education of children and supervising adults about anaphylaxis recognition and first-aid treatment.
Related Concept Videos
01:30Allergic Reactions: Anaphylaxis
02:06Allergic Reactions
01:30Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
01:28Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
01:30Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...